Senestech (NASDAQ:SNES) Major Shareholder Acquires $84,623.22 in Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 42,739 shares of Senestech stock in a transaction that occurred on Monday, February 2nd. The stock was bought at an average price of $1.98 per share, with a total value of $84,623.22. Following the purchase, the insider owned 593,785 shares of the company’s stock, valued at $1,175,694.30. This trade represents a 7.76% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, January 30th, Glenbrook Capital Management bought 5,399 shares of Senestech stock. The shares were purchased at an average cost of $1.87 per share, for a total transaction of $10,096.13.

Senestech Trading Down 3.3%

Senestech stock opened at $1.78 on Friday. The business has a 50 day moving average price of $2.29 and a two-hundred day moving average price of $3.57. The company has a quick ratio of 14.73, a current ratio of 15.75 and a debt-to-equity ratio of 0.01. Senestech, Inc. has a 12 month low of $1.30 and a 12 month high of $6.24. The stock has a market cap of $9.29 million, a price-to-earnings ratio of -0.49 and a beta of 0.21.

Senestech (NASDAQ:SNES) last announced its quarterly earnings data on Monday, November 10th. The company reported ($0.28) earnings per share for the quarter, topping the consensus estimate of ($0.35) by $0.07. The company had revenue of $0.69 million for the quarter, compared to analyst estimates of $0.73 million. Senestech had a negative return on equity of 98.35% and a negative net margin of 253.54%. As a group, equities analysts forecast that Senestech, Inc. will post -10.22 EPS for the current year.

Institutional Investors Weigh In On Senestech

A number of hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC bought a new position in Senestech during the 2nd quarter valued at about $59,000. Diversify Advisory Services LLC bought a new position in shares of Senestech in the fourth quarter valued at approximately $34,000. Essex Investment Management Co. LLC bought a new position in shares of Senestech in the third quarter valued at approximately $115,000. Millennium Management LLC acquired a new position in shares of Senestech in the 3rd quarter worth approximately $126,000. Finally, Jane Street Group LLC bought a new stake in Senestech during the 2nd quarter worth approximately $161,000. Institutional investors and hedge funds own 5.19% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a research note on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold”.

Senestech Company Profile

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.